Literature DB >> 6318144

Purification of a calcium-activated neutral proteinase from bovine brain.

N L Banik, E L Hogan, M G Jenkins, J K McDonald, W W McAlhaney, M B Sostek.   

Abstract

A calcium-activated neutral proteinase (CANP) resolved into three components has been partially purified from bovine brain. The method of isolation has resulted in 22,000, 7,100, and 8,000-fold purification for CANP I, II and III respectively. All three fractions require Ca2+ for activation. The characterization of the purified CANP I has shown that it is activated by 250 microM Ca2+ and the enzyme loses its activity when incubated in the presence of Ca2+ without substrate. Mg2+ is ineffective. The enzyme degrades neurofilament triplet proteins, tubulin and casein efficiently. The myelin basic protein is hydrolyzed after longer incubation. Bovine serum albumin and histones are unaffected. The enzyme is active at pH 5.5 to 9.0 with optimum between pH 7.5 and 8.5. It has a Km of 1.8 X 10(-7) M for the 69,000 dalton neurofilament protein. The enzyme is inhibited by sulphydryl blocking reagents and also by EGTA, leupeptin and E-64c. The SDS-PAGE analysis of the enzyme fractions has shown a major band at 66-68,000 daltons and two minor bands at 60,000 and 48-50,000 daltons for CANP I; a major band at 48-50,000 daltons and a minor band at 30-32,000 daltons for CANP II and a predominant doublet at 30-32,000 daltons with a minor band at 48-50,000 daltons for CANP III. The degradation of neurofilament proteins suggests that the CANP(s) may be involved in the turnover of these proteins.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6318144     DOI: 10.1007/bf00964996

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  39 in total

1.  Vesicular disruption of myelin simulated by exposure of nerve to calcium ionophore.

Authors:  W W Schlaepfer
Journal:  Nature       Date:  1977-02-24       Impact factor: 49.962

2.  A NEUTRAL, CALCIUM-ACTIVATED PROTEINASE FROM THE SOLUBLE FRACTION OF RAT BRAIN.

Authors:  G GUROFF
Journal:  J Biol Chem       Date:  1964-01       Impact factor: 5.157

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  The role of intracellular proteases in brain tumor.

Authors:  I Nishiura; H Handa; T Murachi
Journal:  Neurol Med Chir (Tokyo)       Date:  1979-01       Impact factor: 1.742

5.  Calcium-dependent neural proteases, widespread occurrence of a species of protease active at lower concentrations of calcium.

Authors:  A Kishimoto; N Kajikawa; H Tabuchi; M Shiota; Y Nishizuka
Journal:  J Biochem       Date:  1981-09       Impact factor: 3.387

6.  Purification and some physico-chemical and enzymic properties of a calcium ion-activated neutral proteinase from rabbit skeletal muscle.

Authors:  J L Azanza; J Raymond; J M Robin; P Cottin; A Ducastaing
Journal:  Biochem J       Date:  1979-11-01       Impact factor: 3.857

7.  Bulk preparation of CNS cytoskeleton and the separation of individual neurofilament proteins by gel filtration: dye-binding characteristics and amino acid compositions.

Authors:  F C Chiu; W T Norton
Journal:  J Neurochem       Date:  1982-11       Impact factor: 5.372

8.  Degradation of cytoskeletal proteins in experimental spinal cord injury.

Authors:  N L Banik; E L Hogan; J M Powers; L J Whetstine
Journal:  Neurochem Res       Date:  1982-12       Impact factor: 3.996

9.  A Ca2+-activated protease possibly involved in myofibrillar protein turnover. Purification from porcine muscle.

Authors:  W R Dayton; D E Goll; M G Zeece; R M Robson; W J Reville
Journal:  Biochemistry       Date:  1976-05-18       Impact factor: 3.162

10.  Muscular dystrophy: inhibition of degeneration in vivo with protease inhibitors.

Authors:  A Stracher; E B McGowan; S A Shafiq
Journal:  Science       Date:  1978-04-07       Impact factor: 47.728

View more
  19 in total

1.  In vivo administration of calpeptin attenuates calpain activation and cardiomyocyte loss in pressure-overloaded feline myocardium.

Authors:  Santhosh K Mani; Hirokazu Shiraishi; Sundaravadivel Balasubramanian; Kentaro Yamane; Meenakshi Chellaiah; George Cooper; Naren Banik; Michael R Zile; Dhandapani Kuppuswamy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-16       Impact factor: 4.733

2.  Calpain inhibition protected spinal cord motoneurons against 1-methyl-4-phenylpyridinium ion and rotenone.

Authors:  S Samantaray; V H Knaryan; C Le Gal; S K Ray; N L Banik
Journal:  Neuroscience       Date:  2011-06-22       Impact factor: 3.590

3.  Chronic intermittent ethanol induced axon and myelin degeneration is attenuated by calpain inhibition.

Authors:  Supriti Samantaray; Varduhi H Knaryan; Kaushal S Patel; Patrick J Mulholland; Howard C Becker; Naren L Banik
Journal:  Brain Res       Date:  2015-06-20       Impact factor: 3.252

4.  Inhibition of Calpain Activation Protects MPTP-Induced Nigral and Spinal Cord Neurodegeneration, Reduces Inflammation, and Improves Gait Dynamics in Mice.

Authors:  Supriti Samantaray; Varduhi H Knaryan; Donald C Shields; April A Cox; Azizul Haque; Naren L Banik
Journal:  Mol Neurobiol       Date:  2015-06-25       Impact factor: 5.590

5.  Calpain inhibition preserves myocardial structure and function following myocardial infarction.

Authors:  Santhosh K Mani; Sundaravadivel Balasubramanian; Juozas A Zavadzkas; Laura B Jeffords; William T Rivers; Michael R Zile; Rupak Mukherjee; Francis G Spinale; Dhandapani Kuppuswamy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-09-04       Impact factor: 4.733

Review 6.  Proteases of human brain.

Authors:  A Pope; R A Nixon
Journal:  Neurochem Res       Date:  1984-03       Impact factor: 3.996

7.  Differential distribution of calpain in human lymphoid cells.

Authors:  R V Deshpande; J M Goust; N L Banik
Journal:  Neurochem Res       Date:  1993-07       Impact factor: 3.996

8.  Postinjury estrogen treatment of chronic spinal cord injury improves locomotor function in rats.

Authors:  Eric A Sribnick; Supriti Samantaray; Arabinda Das; Joshua Smith; D Denise Matzelle; Swapan K Ray; Naren L Banik
Journal:  J Neurosci Res       Date:  2010-06       Impact factor: 4.164

9.  Critical role of calpain in spinal cord degeneration in Parkinson's disease.

Authors:  Supriti Samantaray; Varduhi H Knaryan; Donald C Shields; Naren L Banik
Journal:  J Neurochem       Date:  2013-08-20       Impact factor: 5.372

10.  Ca2+-mediated degradation of central nervous system (CNS) proteins: topographic and species variation.

Authors:  N L Banik; R D Happel; M B Sostek; F C Chiu; E L Hogan
Journal:  Metab Brain Dis       Date:  1987-06       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.